90Y-Ibritumomab Tiuxetan (Zevalin®) Consolidation of First Remission In Advanced-Stage Follicular Non-Hodgkin's Lymphoma: Updated Results After a Median Follow-up of 66.2 Months From the International, Randomized, Phase III First-Line Indolent Trial (FIT) In 414 Patients
| Autor: | Hagenbeek, Anton, Radford, John *, Van Hoof, Achiel, Vitolo, Umberto *, Rohatiner, Ama Z.S. *, Salles, Gilles *, Soubeyran, Pierre *, Tilly, Herve, Delaloye, Angelika Bischof *, van Putten, Wim L.J. *, Morschhauser, Franck * |
|---|---|
| Zdroj: | In Blood 19 November 2010 116(21):594-594 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|